StockDriftsStockDriftsMyeongin Pharmaceutical (317450) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Myeongin Pharmaceutical is dated 2025-10-01; the most recent is 2026-05-08. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | BUY | 수증 | 이선영 Seonyoung Lee | - | 1.8M | ₩53,800 | -2.2% | ₩94.7B ($65.8M) |
| 2026-05-08 | BUY | 수증 | 이자영 Lee Ja-young | - | 1.5M | ₩53,800 | -2.2% | ₩80.7B ($56.0M) |
| 2026-05-08 | SELL | 증여 | 이행명 name of implementation | Chairman | -100.0K | ₩53,800 | +2.2% | ₩5.4B ($3.7M) |
| 2026-05-08 | SELL | 증여 | 이행명 name of implementation | Chairman | -630.0K | ₩53,800 | +2.2% | ₩33.9B ($23.5M) |
| 2026-05-08 | SELL | 증여 | 이행명 name of implementation | Chairman | -330.0K | ₩53,800 | +2.2% | ₩17.8B ($12.3M) |
| 2025-10-01 | BUY | 신규상장 | 이동철 Lee Dong-cheol | president | 50.0K | ₩121,900 | -49.1% | ₩6.1B ($4.2M) |
| 2025-10-01 | BUY | 신규상장 | 이행명 name of implementation | CEO | 7.4M | ₩121,900 | -49.1% | ₩905.5B ($628.8M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Myeongin Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.